Grant Paulsen

Cincinnati Children's Hospital Medical Center

Also affiliated with University of Cincinnati Medical Center

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study”.

Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad235

N/A

0.672DataRank · unranked

25 citations

Robert W. Frenck, Kay M. Tomashek, Rodolfo Alarcón, Elizabeth Hensel, Ashley A. Lowe +5 more

The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad534

N/A

0.603DataRank · unranked

16 citations

Lubna Hamdan, Daniel E. Dulek, Carrie L. Kitko, Einas Batarseh, Zaid Haddadin +38 more

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf144

N/A

0.304DataRank · unranked

6 citations

James D. Campbell, Grant Paulsen, Sabine Schnyder Ghamloush, W. Xu, Lingyi Zheng +7 more

Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae454

N/A

0.270DataRank · unranked

4 citations

Andrew J. Spieker, Haya Hayek, Jennifer E. Schuster, Lubna Hamdan, Daniel E. Dulek +41 more

A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age

Vaccine(2025)10.1016/j.vaccine.2025.126991

N/A

0.226DataRank · unranked

3 citations

Emmanuel B. Walter, Michael J. Smith, James Campbell, Hana M. El Sahly, Jennifer A. Whitaker +20 more

Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®

Vaccine(2025)10.1016/j.vaccine.2024.126702

N/A

0.173DataRank · unranked

2 citations

Rebecca C. Brady, Lisa A. Jackson, Paul Goepfert, Hana M. El Sahly, Robert L. Atmar +8 more

385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.455

N/A

0.104DataRank · unranked

1 citations

Lawrence Sher, Charu Sabharwal, Nicholas Kitchin, Sungeen Hill, Emily Wasserman +19 more

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units

Clinical Infectious Diseases(2025)10.1093/cid/ciaf379

N/A

0DataRank · unranked

0 citations

Daniel S. Graciaa, Tara M Babu, Rhea N. Coler, Grant Paulsen, Daniel F. Hoft +5 more

Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients

Blood Advances(2024)10.1182/bloodadvances.2023012118

N/A

0DataRank · unranked

4 citations

Daniel E. Dulek, Joshua D. Simmons, Haya Hayek, James D. Chappell, Cindy Hager Nochowicz +19 more